---
document_datetime: 2023-09-21 19:13:57
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/repaglinide-krka-epar-all-authorised-presentations_en.pdf
document_name: repaglinide-krka-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.0455449
conversion_datetime: 2025-12-26 19:29:32.754462
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Name             | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging                 | Package size   |
|-----------------|------------------|------------|-----------------------|---------------------------|---------------------------|----------------|
| EU/1/09/579/001 | Repaglinide Krka | 0,5 mg     | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 30 tablets     |
| EU/1/09/579/002 | Repaglinide Krka | 0,5 mg     | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 60 tablets     |
| EU/1/09/579/003 | Repaglinide Krka | 0,5 mg     | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 90 tablets     |
| EU/1/09/579/004 | Repaglinide Krka | 0,5 mg     | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 120 tablets    |
| EU/1/09/579/005 | Repaglinide Krka | 0,5 mg     | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 270 tablets    |
| EU/1/09/579/006 | Repaglinide Krka | 0,5 mg     | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 360 tablets    |
| EU/1/09/579/007 | Repaglinide Krka | 1 mg       | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 30 tablets     |
| EU/1/09/579/008 | Repaglinide Krka | 1 mg       | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 60 tablets     |
| EU/1/09/579/009 | Repaglinide Krka | 1 mg       | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 90 tablets     |
| EU/1/09/579/010 | Repaglinide Krka | 1 mg       | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 120 tablets    |
| EU/1/09/579/011 | Repaglinide Krka | 1 mg       | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 270 tablets    |
| EU/1/09/579/012 | Repaglinide Krka | 1 mg       | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 360 tablets    |
| EU/1/09/579/013 | Repaglinide Krka | 2 mg       | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 30 tablets     |
| EU/1/09/579/014 | Repaglinide Krka | 2 mg       | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 60 tablets     |
| EU/1/09/579/015 | Repaglinide Krka | 2 mg       | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 90 tablets     |
| EU/1/09/579/016 | Repaglinide Krka | 2 mg       | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 120 tablets    |
| EU/1/09/579/017 | Repaglinide Krka | 2 mg       | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 270 tablets    |
| EU/1/09/579/018 | Repaglinide Krka | 2 mg       | Tablet                | Oral use                  | blister (OPA/Al/PVC - Al) | 360 tablets    |